EUVIMEDEUVIMED entdecken
Crossref

Clinical Features of COVID-19 in Patients with Congenital Central Hypoventilation Syndrome

Ajay S Kasi iD, Melinda Riccitelli, Sheila S Kun, Adrianna L Westbrook, George L Silva, Thomas G Keens, Lokesh Guglani

Pediatric Allergy, Immunology, and Pulmonology · 2023

DOI: 10.1089/ped.2023.0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy, Immunology, and Pulmonology, 2023. Verfasst von Ajay S Kasi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Pulmonology, Department of Pediatrics, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, Homeodomain Proteins. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical course of COVID-19 in patients with congenital central hypoventilation syndrome (CCHS) is unknown.

Methods

We conducted a cross-sectional questionnaire study in 43 patients with CCHS who had COVID-19.

Results

The median age of patients was 11 [interquartile range (IQR) 6–22] years and 53.5% required assisted ventilation (AV) through tracheostomy. Disease severity ranged from asymptomatic infection (12%) to severe illness with hypoxemia (33%) and hypercapnia requiring emergency care/hospitalization (21%), increased AV duration (42%), increased ventilator settings (12%), and supplemental oxygen demand (28%). The median duration to return to baseline AV ( n = 20) was 7 (IQR 3–10) days. Patients with polyalanine repeat mutations required increased AV duration compared with those with nonpolyalanine repeat mutations ( P = 0.048). Patients with tracheostomy required increased oxygen during illness ( P = 0.02). Patients aged ≥18 years took longer to return to baseline AV ( P = 0.04).

Conclusions

Our study suggests that all patients with CCHS should be vigilantly monitored during COVID-19 illness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Homeodomain ProteinsAdultYoung AdultHypoventilationAdolescentTranscription FactorsSleep Apnea, CentralCross-Sectional StudiesChildOxygenHumans

Stichwörter der Autor:innen

CCHSCOVID-19PHOX2Bhome mechanical ventilationtracheostomy

Substanzen

Homeodomain ProteinsTranscription FactorsOxygen

Autor:innen und Institutionen

  • Division of Pediatric Pulmonology, Department of Pediatrics, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Congenital Central Hypoventilation Syndrome (CCHS) Network, Encinitas, California, USA.
  • Division of Pediatric Pulmonology and Sleep Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Pediatric Biostatistics Core, Department of Pediatrics, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

ORCID-Profile: Ajay S Kasi

Zitieren

APA

Kasi, A. S., Riccitelli, M., Kun, S. S., Westbrook, A. L., Silva, G. L., Keens, T. G., & Guglani, L. (2023). Clinical Features of COVID-19 in Patients with Congenital Central Hypoventilation Syndrome. Pediatric Allergy, Immunology, and Pulmonology. https://doi.org/10.1089/ped.2023.0004

Vancouver

Kasi AS, Riccitelli M, Kun SS, Westbrook AL, Silva GL, Keens TG, et al. Clinical Features of COVID-19 in Patients with Congenital Central Hypoventilation Syndrome. Pediatric Allergy, Immunology, and Pulmonology. 2023. doi:10.1089/ped.2023.0004

BibTeX
@article{Kasi2023,
  author = {Kasi, Ajay S and Riccitelli, Melinda and Kun, Sheila S and Westbrook, Adrianna L and Silva, George L and Keens, Thomas G and Guglani, Lokesh},
  title = {Clinical Features of COVID-19 in Patients with Congenital Central Hypoventilation Syndrome},
  journal = {Pediatric Allergy, Immunology, and Pulmonology},
  year = {2023},
  doi = {10.1089/ped.2023.0004}
}
Kostenlos starten →